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Skeletal muscle myofibrillar and sarcoplasmic protein synthesis
rates are affected differently by altitude-induced hypoxia in
native lowlanders
Abstract
As a consequence to hypobaric hypoxic exposure skeletal muscle atrophy is often reported. The
underlying mechanism has been suggested to involve a decrease in protein synthesis in order to
conserve O(2). With the aim to challenge this hypothesis, we applied a primed, constant infusion of
1-(13)C-leucine in nine healthy male subjects at sea level and subsequently at high-altitude (4559 m)
after 7-9 days of acclimatization. Physical activity levels and food and energy intake were controlled
prior to the two experimental conditions with the aim to standardize these confounding factors. Blood
samples and expired breath samples were collected hourly during the 4 hour trial and vastus lateralis
muscle biopsies obtained at 1 and 4 hours after tracer priming in the overnight fasted state. Myofibrillar
protein synthesis rate was doubled; 0.041±0.018 at sea-level to 0.080±0.018%⋅hr(-1) (p<0.05) when
acclimatized to high altitude. The sarcoplasmic protein synthesis rate was in contrast unaffected by
altitude exposure; 0.052±0.019 at sea-level to 0.059±0.010%⋅hr(-1) (p>0.05). Trends to increments in
whole body protein kinetics were seen: Degradation rate elevated from 2.51±0.21 at sea level to
2.73±0.13 µmol⋅kg(-1)⋅min(-1) (p = 0.05) at high altitude and synthesis rate similar; 2.24±0.20 at sea
level and 2.43±0.13 µmol⋅kg(-1)⋅min(-1) (p>0.05) at altitude. We conclude that whole body amino acid
flux is increased due to an elevated protein turnover rate. Resting skeletal muscle myocontractile protein
synthesis rate was concomitantly elevated by high-altitude induced hypoxia, whereas the sarcoplasmic
protein synthesis rate was unaffected by hypoxia. These changed responses may lead to divergent
adaptation over the course of prolonged exposure.
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Abstract
As a consequence to hypobaric hypoxic exposure skeletal muscle atrophy is often reported. The underlying mechanism has
been suggested to involve a decrease in protein synthesis in order to conserve O2. With the aim to challenge this
hypothesis, we applied a primed, constant infusion of 1-13C-leucine in nine healthy male subjects at sea level and
subsequently at high-altitude (4559 m) after 7–9 days of acclimatization. Physical activity levels and food and energy intake
were controlled prior to the two experimental conditions with the aim to standardize these confounding factors. Blood
samples and expired breath samples were collected hourly during the 4 hour trial and vastus lateralis muscle biopsies
obtained at 1 and 4 hours after tracer priming in the overnight fasted state. Myofibrillar protein synthesis rate was doubled;
0.04160.018 at sea-level to 0.08060.018%?hr21 (p,0.05) when acclimatized to high altitude. The sarcoplasmic protein
synthesis rate was in contrast unaffected by altitude exposure; 0.05260.019 at sea-level to 0.05960.010%?hr21 (p.0.05).
Trends to increments in whole body protein kinetics were seen: Degradation rate elevated from 2.5160.21 at sea level to
2.7360.13 mmol?kg21?min21 (p = 0.05) at high altitude and synthesis rate similar; 2.2460.20 at sea level and
2.4360.13 mmol?kg21?min21 (p.0.05) at altitude. We conclude that whole body amino acid flux is increased due to an
elevated protein turnover rate. Resting skeletal muscle myocontractile protein synthesis rate was concomitantly elevated by
high-altitude induced hypoxia, whereas the sarcoplasmic protein synthesis rate was unaffected by hypoxia. These changed
responses may lead to divergent adaptation over the course of prolonged exposure.
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Introduction
Long-term (75 days) exposure of healthy lowlanders to high-
altitude (5250 m at Mount Everest base camp) induces loss of
skeletal muscle mass and single fiber atrophy in m. vastus lateralis
and m. biceps brachii [1]. Similar results have been obtained in
subjects residing for 40 days in a hypobaric chamber [2]. In
mountaineers climbing in the Himalayas severe loss .20% of
single fiber area has been reported in biopsies obtained upon
return to sea level [3,4]. Thus, hypoxic exposure has in several
studies been shown to be detrimental for skeletal muscle mass.
However, contrasting results have also been reported. For
example, following 56 days at 4100 m altitude no significant
changes in single fiber cross sectional area was observed [5].
Besides the lower residing altitude in this study, subjects had free
access to physical activities such as soccer, hiking, and jogging,
which may have counteracted the severity of muscle loss and thus
its detection. Following a 21-day expedition culminating with the
assent to 6194 m, six mountaineers experienced no significant
muscle loss [6]. Thus, total time of exposure, the degree of
hypoxia, physical activity levels, and food intake are all factors,
which may markedly influence the adaptation of skeletal muscle to
hypoxia.
In studies, applying indirect measures of protein turnover, in
vitro models provide results that suggests that attenuated energy
turnover and loss of muscle mass may be developed at hypoxia
exposure due to a decrease in overall protein turnover rate [7–10].
Surprisingly, Vigano and co-workers observed no marked changes
in translation regulating following 7–9 days of stay at 4559 m
altitude [11]. Exemplified by the total mammalian target of
rapamycin (mTOR), a master regulator of protein synthesis, they
found a slight decrease in its protein content, unfortunately with
no measures of its phosphorylation status or activity [11]. The
protein expression and phosphorylation state of the eukaryotic
translation initiation factor 2 alpha (eIF2a) was unchanged [11],
which was also the case for the protein concentration of the
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15606
hypoxia inducible factor (HIF). In a previous publication however,
the HIF gene was shown to be markedly increased at the
transcriptional level [12].
A direct measurement of the protein kinetics processes is though
more valid to decide whether altitude affects protein turnover.
Using the stable isotope methodology, Imoberdorf and co-workers
assessed muscle protein synthesis rate after exposure to high
altitude [13]. They showed that in a group of subjects, investigated
acutely after active ascent to high-altitude, mixed muscle protein
synthesis rate was higher compared to in a group that was flown to
the altitude and compared to the rate at sea level [13]. In this study
the measurements may have been affected by the differences in
ascent modality and the short acclimatization time allowed at
altitude prior to measurements. Hence, from cell culture
experiments it is known that some metabolic changes to hypoxic
exposure takes place in a time-dependent manner; such as
decrease in cellular ATP concentration and a decrease in oxygen
consumption to protein synthetic processes [7], which means that
some exposure time may be needed to allow the adaptation to
occur.
We therefore hypothesized that skeletal muscle protein synthesis
could be affected by high-altitude induced hypoxia if longer
exposure time would have been allowed. Therefore, to study
whole body and skeletal muscle protein kinetics, we completed
trials with stable isotopically-labeled amino acid infusions at sea
level and 7–9 days after ascent to high altitude (4559 m).
Methods
Subjects
Nine healthy, physically active male subjects participated in the
study. They ranged in age from 24 to 30 years, had an average
height of 18061 cm (mean 6 SEM), and a mean weight of
7862 kg. Not all data points were obtained in all subjects during
the altitude trials, and the exact n is given in tables/figures where
needed. Results describing altitude induced changes in skeletal
muscle proteins involved in iron transport, tricarboxylic acid
(TCA) cycle, oxidative phosphorylation, and oxidative stress
responses from the same study have been published elsewhere
[11,12].
Ethics Statement
The study conformed with guidelines laid down in the
Declaration of Helsinki II and was approved by the Copenhagen
and Frederiksberg Ethics Committee, Denmark. After being given
both written and oral information on the experimental protocol
and procedures, the subjects gave their informed, written consent
to participate.
Experimental design
In April all subjects reported to the laboratory at sea level in
Copenhagen three days prior to the experiments and were not
allowed to leave the building until experiments had finished. Most
of the time was passed watching TV, studying, working on
computers, or conversation. During their indoor confinement the
subjects had access to a broad variety of food and the subjects
choose themselves what to eat at all times. All food intakes were
registered. The day before the experiment no caffeine containing
substances was allowed from 6 pm, and the subjects fasted from 8
pm until after completion of the experiments the following day.
The next morning at 8 am the experiments were initiated and the
protocol is described in the paragraph Experimental protocol.
In late August all subjects were flown to Italy and brought to
3200 m altitude by bus and lift. After 2–3 hours of mountain
walking all subjects arrived at the Gnifetti hut at 3647 m and
spend two nights in order to minimize the risk of acute mountain
sickness (assessed by Lake Louise scores). The experimental
facilities of the Margeritha hut (4559 m altitude) were reached
after 5–7 hours of mountain/glacier walking on day 3 and subjects
resided here until the experiments were started 7–9 days after
arrival to this altitude. The Margeritha hut is a modern building
where parts of the second floor are allocated specifically for
scientific projects. The building is well insulated, has electricity,
and comfortable living and kitchen facilities, and the experimental
settings cannot be compared to the previous studies conducted in
for example the base camp of Mount Everest where low
temperatures etc may influence the results.
As at sea level, all subjects were confined to indoor activities
three days prior to the experiments and were not allowed outside
in an attempt to standardize energy expenditure. We had brought
an exactly matched amount of food as the subjects ate during the
sea level experiments and the subjects consumed a similar diet as
they did at sea level during this period. The restrictions to food
prior to the experiments were the same as they were initiated at
sea level.
Arterial blood sample
Approximately 10 days after the completion of the experiments
at sea level an arterial blood sample was taken for other purposes
[14]. Two days after the subjects had completed the experimental
trials at altitude, an arterial blood sample was obtained while still
at altitude. Experimental protocol
Subjects were studied overnight fasting and in the supine
position. A 20 G venflon (BD Venflon, Sweden) was inserted in an
antecubital vein in both arms, and one was used for infusions and
the other for blood sampling. After a priming dose of 1-13C-
leucine (7.0 mmol?kg21) added H13CO3 (2.5 mmol?kg
21) to label
the carbondioxide pool with 13C as well, the constant infusion of
1-13C-leucine (0.15 mmol?kg21?min21) was initiated and contin-
ued for 4 hours. The stable isotope tracers were sterility and
pyrogenity tested and 99% enriched and purchased from Cam-
bridge Isotopes Laboratories (Andover, MA, USA). They were
dissolved in sterile saline prior infusion and sterilized through a
0.2 mm disposable filter (Sartorius, Hannover, Germany). Muscle
biopsies were obtained prior to any infusions and after 1 and
4 hours of infusions. Biopsies were obtained from vastus lateralis
muscle through a new incision after local anesthesia (1% lidocaine)
using a 5 mm Bergstrom needle with suction and were always
obtained from the same, non-dominant leg.
Before and one day after return to sea level all subjects were
scanned for body composition in a dual-energy X-ray absorpti-
ometer (DEXA; Lunar, GE Medical Systems, Madison, WI,
USA). For more detailed subject characteristic see reference [14].
Measurements
Blood samples were obtained pre infusion and at every hour
during the infusion in EDTA containing tubes and was centrifuged
to obtain plasma, which was stored at –80uC for later analysis of
hormone concentrations and stable isotope abundances. Whole
body O2 uptake (VO2), CO2 production (VCO2), and expired
minute ventilation (VE) were measured for 15 minutes pre infusion
and at every hour during the infusion (Quark b2, Cosmed Srl.,
Rome, Italy). Based on ambient conditions on the experimental
days the gas analyser and the flowmeter were calibrated with high
precision gases. Expired air was also collected in a Douglas bag
and transferred to vacuum glass containers (BD Vacutainer
Systems, Plymouth, UK) for later analysis of 13CO2 enrichments.
Human Muscle Protein Synthesis Rate during Hypoxia
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Analysis
Plasma concentrations for insulin (kit: DYC1544-2), human
growth hormone (kit: DGH00), cortisol (kit: KGE008), and
testosterone (kit: KGE010) were assessed by available ELISA kits
(R6D Systems, Minneapolis, MN, USA) and insulin-like growth
factor-1 (ELH-IGFBP1-001) with ELISA kits (RayBio, Norcross,
GA, USA) applying the prescribed procedures.
The 13C-leucine tracer concentration in the infusate was
determined using the internal tracer standard method: adding a
known amount of L-[5,5,5-D3]-leucine to the sample and relating
the fragment peak of [M+3] to the infused isotope peak [M+1]
with M equal to m/z= 302 based on the obtained GC/MS
chromatograms (gas chromatograph; Trace GC 2000 series and
mass spectrometer; Automass Multi, Thermo Quest Finnigan,
Paris, France) using a capillary column (CP-Sil 8 CB low bleed
30 m60.32 mm, coating 0.25 mm, ChromPack, Varian, Palo
Alto, CA) to isolate leucine and the EI-mode to create the
fragment-ions. Based on the pump recorded infusion speed and
the measured leucine tracer concentration, the delivery of leucine
tracer to the subjects was calculated.
Breath CO2 was analyzed for
13C abundance originating from
oxidation of the 13C-leucine tracer on the IRMS system (isotope
ratio mass spectrometry, Delta Plus XL, Thermo Finnigan,
Bremen, Germany) with CO2 separated by a CP-PoraPLOT Q
column, 27.5 m60.32 mm610 mm (ChromPack, Varian, Palo
Alto, CA).
The surrogate measure of the precursor pool for protein
synthesis with leucine as the traced amino acid, plasma 13C-
ketoisocaproic acid (KIC) abundance was used [15] and measured
at GC/MS system (gas chromatograph; Trace GC 2000 series and
mass spectrometer; Automass Multi, Thermo Quest Finnigan,
Paris, France). A capillary column (CP-Sil 8 CB low bleed
30 m60.32 mm, coating 0.25 mm, ChromPack, Varian, Palo
Alto, CA) was used to separate the compound and that was
analyzed using the EI-mode to fragment the molecule measuring
on the ion m/z= 232. Briefly, plasma proteins were precipitated
from 140 mL plasma with ethanol and the supernatant was dried
under N2 at 50uC. With 200 mL acidified 2% w/v o-phenylene-
diamine in 200 mL Millipore water the substrates were prepared
for the derivatization using pyridine and BSTFA +1% TMCS
(#38831, Pierce, Bie & Berntsen & VWR International, Rødovre,
Denmark).
The protein-bound leucine abundance was measured by GC-C-
IRMS system (chromatography–combustion–isotope ratio mass
spectrometry, Delta Plus XL, Thermo Finnigan, Bremen,
Germany), where the leucine was isolated by a capillary column
(CP-Sil 19 CB 60 m60.25 mm, coating 1.5 mm, ChromPack,
Varian, Palo Alto, CA). The myofibrillar and sarcoplasmic
protein-fractions were separated from a muscle homogenate using
a common solubility/centrifugation procedure [16]. After homog-
enized in buffer (0.15 M NaCl, 5 mM EDTA, 0.1% Triton X-
100, and 0.02 M Tris (pH 7.4)) using an automatic FastPrep
homogenizer (model 120A-230, Thermo Savant, Holbrook, NY),
the myofibrillar and collagenous proteins were precipitated by
centrifugation (1600 g, 4uC, 20 min). From the supernatant, the
sarcoplasmic proteins were precipitated with 2.36 vol ice-cold
ethanol and spun (1600 g, 4uC, 20 min). The myofibrillar proteins
were resuspended in 0.7 M KCl and after centrifugation (1600 g,
4uC, 20 min) they were subsequently precipitated from the
supernatant with 2.36 vol ice-cold ethanol. Protein pellets were
then hydrolyzed in 6 M HCl (110uC for 18 h). The constituent
amino acids were purified by cation exchange resin (Dowex AG-
50W, Bio-Rad, Copenhagen, Denmark) and derivatized as their
N-acetyl n-propyl (NAP) esters.
Calculations
All whole body ventilation and leucine-based results are
reported as the mean of data obtained at 3 and 4 hours whereas
leucine incorporation into myofibrillar and sarcoplasmic protein
fractions is determined from 1–4 hours of infusion. Intracellular
leucine is in equilibrium with its transaminated product, the alpha-
ketoisocaproic acid (KIC). Since the leucine metabolism occurs at
the intracellular site, the venous enrichment of 13C-KIC more
accurately reflects the intracellular abundance of 13C-leucine than
the venous 13C-leucine [15].
Whole body leucine rate of appearance (Ra, leu), which is an
estimate of whole body protein breakdown, was calculated using:
Infusion ratetracer ? EKIC, estimate of intracellular tracer
21.
The underlying assumption for the applied tracer calculations is
that steady state is present for the tracer kinetics, i.e. leucine rate of
appearance, a measure of whole body leucine release Ra, leu =Rd, leu
(leucine rate of disappearance, an estimate of whole body disposal of
leucine). Since leucine can be oxidized, not all of the ‘disappearing’
leucine goes for synthesis. Therefore, non-oxidative whole body
leucine rate of disappearance (NOLD) rate, which is an estimate of
whole body protein synthesis, is calculated: NOLDleu=Rd, leu –
Oxleu. Leucine oxidation rate (Oxleu) was calculated using the
following equation: ECO2 ? CO2 production rate ? bicarbonate
correction factor 0.81 ? EKIC, estimate of intracellular tracer
21, where the
bicarbonate correction factor of 0.81 is a standard value for the
detainment of CO2 in the metabolism [17]. The CO2 production
rate was calculated using the equation: VCO2 ? (22.4 ? Body
weight)21 ? 1000, where the CO2 production was found by
analyzing the expired gas collected in the Douglas bags (nondiffus-
ible Douglas bag, Hans Rudoph).
The protein fractional synthesis rate (FSR) was calculated using
the precursor-product equation: FSR=DEproduct?Eprecursor
21?
Dtime21, where DEproduct is the change in
13C-leucine tracer
enrichment in two tissue samples taken with a time interval of
Dtime hours. Eprecursor is the average precursor pool enrichment
during Dtime hours determined by the valid surrogate measure of
venous 13C-KIC enrichment [15].
The group-mean 13C-KIC-enrichments, used as a valid
estimate of the protein synthesis precursor pool 13C-leucine-
enrichment [15,18], were found to be slightly higher towards the
end of the tracer-incorporation period than in the beginning. Such
minor fluctuations and changes in tracer steady state are often seen
in tracer studies applying the primed-continuous infusion protocol,
as the perfect priming is hard to calculate. When using 13C-leucine
as a tracer and venous 13C-KIC as a derived estimate of the
intracellular tracer abundance, those are thought to be equilibrat-
ed during such minor drifts in tracer abundance and thus are
ascribed to reflect the actual precursor enrichment. Thus, by using
a weighted mean of the precursor pool enrichment the minor drift
towards higher enrichments is not supposed to violate the
underlying assumptions for the FSR calculations.
Statistics
Values obtained at sea level and at high altitude were compared
by a parametric Students paired t-tests. The precursor enrich-
ments at the single time points were compared by a two-way
ANOVA with repeated measures. One subject could not complete
the infusion trial at high altitude, thus total number of skeletal
muscle protein synthesis rates is eight. Due to technical problems
with the gas collections the whole body protein kinetics calculated
from the leucine tracer data only exist for six subjects. Values are
reported as mean 6 SEM. Statistical significance was obtained
when the p-value was ,0.05. Analyses were performed in Prism
4.0 (GraphPad software, San Diego, CA, USA).
Human Muscle Protein Synthesis Rate during Hypoxia
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Results
Subject characteristics
High altitude exposure did not influence body weight (78.362.3
to 77.962.9 kg), resting metabolic rate (212632 to
221622 mL?min21) or VO2max measured before high altitude
exposure and one day after return to sea level (4.460.1 and
4.460.1 L?min21, or 56.262.0 and 56.562.1 mL?kg21?min21,
respectively). DEXA scans revealed that also the body composition
was not altered, i.e. at sea level and high-altitude fat mass was
13.464.2 and 13.264.5 kg, respectively and lean body mass was
63.766.1 and 63.666.1 kg, respectively.
Arterial blood gasses
Hemoglobin concentration was increased from 14468 to
169613 g?L21 from sea level to altitude, and PaCO2 reduced
from 40.462.0 to 29.261.9 mmHg. Likewise PaO2 and SaO2
were decreased from 103.2613.8 and 98.660.5 to
50.563.2 mmHg and 83.462.7%, respectively. As a consequence
of these changes, arterial O2 content remained unchanged and
was 199610 at sea level and 191618 mL?L21 at altitude.
Whole body protein turnover determined with the
leucine tracer
Resting and fasting whole body leucine rate of appearance (Ra),
an estimate of protein degradation, tended to be increased at high
altitude compared to sea level (Table 1, p = 0.05, n= 6). Further,
non-oxidative leucine disappearance (NOLD), an estimate of
protein synthesis, and leucine oxidation also showed a numerical
increase at altitude although the change did not reach statistical
significance (Table 1, p = 0.19 and p= 0.16, respectively, n = 6).
Muscle protein synthesis rate
Enrichment of the surrogate measure of muscle protein
synthesis precursor estimated by the venous plasma 13C-KIC
enrichments is reported in Table 2. A slight increase over the
course of the FSR-determination from 1 to 4 hours after start of
infusion (p,0.001) was seen as well as an effect of altitude
(p,0.05) with the enrichment at altitude being 13% lower than at
sea level. Vastus lateralis muscle myofibrillar protein fractional
synthesis rate in the resting, overnight fasted state was enhanced
from 0.04160.018 at sea level to 0.08060.018%?hr21 following
7–9 days of high altitude acclimatization (p,0.05, Figure 1A),
whereas the sarcoplasmic protein synthesis rate was unchanged by
altitude exposure, 0.05260.019%?hr21 at sea level and
0.05960.010%?hr21 at altitude (p.0.05, Figure 1B).
Hormones
Plasma concentrations of human growth hormone, cortisol,
testosterone, and insulin-like growth factor I (IGF-I) remained
unchanged with altitude exposure, whereas insulin concentrations
increased from 4.960.4 to 7.761.1 mlU?mL21 (p,0.05, Table 3).
Discussion
Loss of skeletal muscle is a common observation when healthy
native lowlanders are exposed to high altitude for prolonged
periods [19]. Furthermore, the mean fiber area in the vastus
lateralis muscle of Aymara Bolivian natives residing in a La Paz at
4100 m is significantly smaller than in native European lowlanders
[5]. Although the atrophic phenomenon at altitude has been
described for decades, the underlying peripheral protein kinetics
and mechanisms remain unresolved and only few human data on
protein turnover in response to hypoxia exist. The main finding in
the present study was that resting, fasting skeletal muscle
sarcoplasmic protein synthesis rate is unchanged after 7–9 days
acclimatization to altitude whereas the contractile protein
synthesis rate is markedly elevated (Figure 1).
The synthesis rate of human skeletal muscle protein has only
sparsely been assessed during hypoxic conditions and data are
somehow contrasting. Imoberdorf and co-workers assessed the
fractional synthesis rate of mixed skeletal muscle protein at sea-
level and divided the subjects into two groups subsequently; one
group that was flown to high altitude and another that walked
from 3220 m up to 3611 m (1.5 hr) on one day and then to
4559 m (4–5 hrs) the next day [13]. Acutely (19–24 hrs) after
arrival at the high altitude destination the trials were conducted,
which revealed an unchanged resting synthesis rate of the mixed
muscle proteins in the passively ascended group and an elevated
synthesis rate in the walking group [13]. Although well-conducted,
the study has two critique points in terms of evaluating how
hypoxia affects skeletal muscle protein synthesis rate. First,
performing the trials shortly after arrival presumably does not
allow sufficient time for relevant hypoxic responses to occur and
thus does not determine whether chronic hypoxia affects protein
synthesis rate. In this regard, rodent studies reveal that the
adaptive response in muscle protein turnover to hypoxic
conditions is affected by time [20,21]. Secondly, the elevated
muscle synthesis rate in the active group may simply be caused by
the physical activity (active ascent) [22,23] conducted one and two
days prior the experimental trial [13], which is a bias with regards
to the hypoxic exposure intervention. In the other human study
examining the response of hypoxia on protein metabolism, the
forearm muscle compartment was shown to slower its protein
synthesis (estimated by leucine uptake) with acute exposure to
hypobaric hypoxia [24]. These divergent results also signify the
importance of evaluating protein kinetics at more protein specific
level, since different protein fractions may diverge in responsive-
ness. Therefore, not necessarily in contrast to previous results
[13,24], the myocontractile protein synthesis rate was elevated
after ,1 week of acclimatization to high altitude (Figure 1A). As
the problem during hypoxic exposures generally is loss of skeletal
muscle mass, the enhanced synthesis rate of the contractile
proteins must be accompanied by an even higher increase in the
protein breakdown rate. That a similar stimulus may have been
applied to the present subjects is implied by the trend toward an
increase in the whole body protein degradation rate (Ra, Table 1).
In the same subjects however, Vigano et al. reported that the
concentration of the muscle myofibrillar protein actin was
unchanged with altitude exposure [11]. Therefore, the measured
overall elevation in protein turnover with hypoxia exposure, which
Table 1. Whole body leucine turnover.
Sea level Altitude p value
Whole body leucine Ra 2.5160.21 2.7360.13 0.05
Leucine oxidation 0.2760.02 0.3160.01 0.16
Non-oxidative leucine Rd 2.2460.20 2.4360.13 0.19
Whole body leucine rate of appearance (Ra), leucine oxidation, and non-
oxidative leucine rate of disappearance (Rd) [mmol?kg21?min21] in male
subjects at sea level and after 7–9 days exposure to high altitude. N = 6, and
values are mean 6 SEM.
doi:10.1371/journal.pone.0015606.t001
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also is likely to have been the case for the myofibrillar protein
breakdown rate, may have been counterbalanced by a concom-
itant increase in the myofibrillar protein synthesis rate. Thereby,
resulting in a steady actin protein concentration and an
undetectable change in muscle mass [11].
In contrast, we found an unaffected synthesis rate of the
sarcoplasmic proteins in skeletal muscle (Figure 1B). Using a
similar muscle protein separation protocol, it has been verified that
the sarcoplasmic protein fraction contains water soluble proteins
present intracellularly as well as subsarcolemmal mitochondrial
proteins [16,25]. Assuming that the overall protein turnover rate is
enhanced, an absence of enhanced protein synthesis rate will result
in net protein breakdown leading to net protein loss. For the
sarcoplasmic proteins this may be the situation and this is in
agreement with the finding from the same muscle specimens
showing a decreased concentration of various metabolic enzymes
and stress responsive proteins [11] as well as several proteins
involved in the oxygen transport [12], of which most presumably
will be present in the sarcoplasmic protein fraction. Although, the
decrements in protein concentrations in these studies were
unexpected for the authors at that time, because most of the
mRNAs coding for those proteins were more concentrated at
altitude [12], the findings are in agreements with decreased
mitochondrial density and content of metabolic enzymes after
prolonged exposure to hypoxia shown in other studies [4,26,27].
Relating to these long-term adaptations, it can therefore be
suggested that the breakdown rate of the proteins in the
sarcoplasmic protein fraction as well as for other proteins in the
body is enhanced, which thereby in the absence of elevated
synthesis rate results in a negative net sarcoplasmic protein
Table 2. Venous plasma KIC and muscle protein bound leucine enrichments.
1 hr 2 hr 3 hr 4 hr
Sea level Venous plasma 13C-KIC 5.7060.16 6.1360.20 6.3360.22 6.5760.25
Myofibrillar protein 1.083560.0003 1.084460.0005
Sarcoplasmic protein 1.088660.0004 1.089860.0005
Altitude Venous plasma 13C-KIC 5.0560.26 5.2760.21 5.5860.19 5.7460.22
Myofibrillar protein 1.084560.0005 1.086160.0007
Sarcoplasmic protein 1.089460.0001 1.090560.0002
Enrichments in the precursor; venous plasma alpha-13C-ketoisocaproic acid (KIC) in percent tracer-to-tracee ratio (TTR) at time points every hour throughout the FSR-
determination period. An effect of time (p,0.001) and altitude (p,0.05) appeared. Isotope ratios of 13C/12C in leucine liberated from the myofibrillar and sarcoplasmic
protein fractions, respectively, in the muscle tissue at 1 and 4 hours at sea level and at altitude. N = 8 and values are mean 6 SEM.
doi:10.1371/journal.pone.0015606.t002
Figure 1. Muscle protein fractional synthesis rate. Resting and
fasting fractional synthesis rate [%?hr21] of A) myofibrillar proteins and
B) sarcoplasmic proteins at sea level and after 7–9 days of
acclimatization to 4559 m altitude. N= 8 and values are mean 6 SEM.
doi:10.1371/journal.pone.0015606.g001
Table 3. Venous plasma hormonal concentrations.
Sea level Altitude p value
Insulin 4.760.4 7.761.1 ,0.05
hGH 2.760.7 1.560.1 Ns
IGF-I 14169 151614 Ns
Testosterone 13.162.2 17.462.9 Ns
Cortisol 88.3615.4 89.3613.0 Ns
Venous plasma concentrations of insulin [mlU?mL21], human growth hormone
[hGH; mlU?mL21], cortisol [ng?mL21], testosterone [pg?mL21], and insulin like
growth factor-1 [ng?mL21] in male subjects at sea level and after 7–9 days
exposure to high altitude. N = 9 and values are mean 6 SEM.
doi:10.1371/journal.pone.0015606.t003
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balance, leading to protein loss. We did not observe any
indications of altered oxidative capacity with hypoxic exposure
in the present study (similar submax and max VO2 at sea level and
with acute normoxia at altitude). Whether, the turnover rates of
the specific proteins leading to the metabolic changes and
decreased oxidative capacity were affected by hypoxia or not or
the changes yet were unable to exert functional changes are
unknown. As tempted to outline, several adaptations have to take
place along the path from changes in gene and protein expression
till detectable physiological manifestations.
Venous plasma KIC is not solely originating from skeletal
muscle, but is released from all cells making the venous plasma
KIC a weighted mean of whole body intracellular leucine
enrichments. It is generally agreed that since skeletal muscle make
up such an abundant tissue, the venous plasma KIC enrichments
is highly reflective of the status in the myocytes [15,18].
Interestingly, we observed a 13% lower enrichment in the KIC
at altitude compared to at sea level (Table 2). Since the enrichment
at steady state is defined as the tracer infusion rate divided by the
rate of appearance of the tracee, the lower enrichment at altitude
is presumably due to a higher rate of appearance and thus flux of
free leucine at altitude. This observation thus coincides with the
trend toward increased whole body leucine flux and significant
increase in leucine rate of appearance (Table 1), which is a
measure of protein degradation. Unfortunately, we do not have
any tissue or protein specific data for degradation, which would
have gained valuable information in combination with the
synthesis results. However, protein specific methods to assess the
protein breakdown rate comparable to the fractional synthesis rate
approach await yet to be developed.
It is not believed that the observed protein turnover is driven by
changes in systemic hormones as we (Table 2) and others [13,28]
have not been able to show changes in a range of potent hormones
except from insulin, which previously has been found to be
increased after hypoxic exposure [28]. Both circulating glucose
and insulin is elevated after acclimatization to high altitude
[28,29], indicating a diminished insulin sensitivity under hypoxic
conditions. It is unlikely that this relatively small increase in insulin
should be responsible for the observed changes in skeletal muscle
protein turnover [30].
It has previously been demonstrated that the hypoxic response
may not be as detrimental for the cell [5] as the in vitro conditions,
which lead to the formulation of the ‘‘Hypoxia Defence
Strategies’’ by Hochachka and co-workers [8]. Thus, a less severe
response than the initiation of the two-phase Defence and Rescue
strategy may be expected. During an exposure to a mild hypoxic
milieu as in the present setting, we propose a remodeling adaptive
response in the skeletal muscle, which initiates an increase in
protein degradation. Subsequently, it is left to the synthetic
processes to reorganize and rebuild the tissue. Whether the net
outcome over time then ends up with a steady or slightly decreased
protein mass is depended on how well the protein synthetic
processes are maintained. The stimulation of protein synthesis may
primarily be through external factors, which at altitude may be
compromised by decreasing food intake, decrease in physical
activity level [19], gastric disorder, minor inflammatory states
[31,32], and various other high-altitude related inconveniences
[33]. The net muscle protein balance may thereby be susceptible
to become negative leading to a net loss of muscle mass as it is
observed in most but not all high-altitude studies. Further, when
the protein turnover rate is high, the protein mass is more
vulnerable to change when small imbalances in net balance
appear. It is known though, that skeletal muscles maintain their
capacity to adapt to endurance training at altitude [34].
Therefore, if the compromising factors for the stimulation of
protein synthetic processes are not sought treated and counter-
acted at high altitude a negative net protein balance seem
unavoidable. In the present study, we sought to match energy
expenditure at altitude with those at sea level and provided the
subjects with excess food, which in our setting may have
maintained the myofibrillar protein synthesis high. Assuming an
overall increased release of amino acids after several days of high
altitude acclimatization, the lack of elevated synthesis rate of the
sarcoplasmic and mitochondrial proteins therefore coincides with
the ubiquitously observed decrease in oxidative capacity following
exposure to high altitude.
The applied tracer approach validly reveals that the adaptation
of synthesis rates of various skeletal muscle protein fractions is
different and future hypoxia-research should focus on describing
the molecular signaling responsible for these divergent adapta-
tions. With regard to the measurement of protein breakdown rate,
no similar protein specific approach exists. However, the whole
body amino acid flux rates assessed here indicate an elevation at
altitude when compared to sea level but these results are
underpowered and not protein specific. Therefore, the adaptation
and regulation of the protein breakdown after acclimatization to
high altitude demands thorough research and improvements in
methodology.
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